Nurix Therapeutics Inc (NRIX)

28.05 -0.11  -0.39% NASDAQ Oct 22, 16:00 28.07 +0.02  +0.07% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All NRIX News

News

View All Events

Events

Date Type Description
02/16/2022 Earnings Results Q4 2021 Earnings Results
10/14/2021 Earnings Results Q3 2021 Earnings Results
07/13/2021 Earnings Results Q2 2021 Earnings Results
05/06/2021 12:00 EST AGM 2020 Annual General Meeting
04/13/2021 Earnings Results Q1 2021 Earnings Results
02/16/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.
  • URL: http://www.nurixtx.com
  • Investor Relations URL: https://ir.nurixtx.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Feb. 16, 2022
  • Last Earnings Release: Oct. 14, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
ETCHX Eventide Healthcare & Life Sciences C 1.50%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.